Novartis AG
Methods of enhancing immune response
Last updated:
Abstract:
The present invention relates to a method of enhancing immune response in a subject.
Status:
Grant
Type:
Utility
Filling date:
3 Oct 2019
Issue date:
29 Jun 2021